NCT03684265View on ClinicalTrials.gov

A Study to Compare the Amount of Meloxicam in the Blood When it is Taken as Capsules or as Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 5, 2018

Primary Completion Date

October 30, 2018

Study Completion Date

November 6, 2018

Conditions
Healthy
Interventions
DRUG

Meloxicam Capsule (Test)

single dose

DRUG

Meloxicam Tablet (Reference)

single dose

Trial Locations (1)

109263

City Clinical Hospital named after V.P. Demikhova Department of Health of Moscow, Moscow

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03684265 - A Study to Compare the Amount of Meloxicam in the Blood When it is Taken as Capsules or as Tablets | Biotech Hunter | Biotech Hunter